[1]
J. Rico-Fontalvo, R. . Daza-Arnedo, J. Cabrales, and J. D. . Montejo-Hernández, “Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits ”, Rev. Colomb. Nefrol., vol. 9, no. 3, Oct. 2022.